Simris Alg AB (publ)

Research Simris Alg AB (publ) (SIMRIS-B) on Bullrun: market cap SEK 148.48M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerSIMRIS-B
ExchangeST
CountrySweden
SectorHealthcare
IndustryBiotechnology
CurrencySEK
Market capSEK 148.48M
Financial periodQ1 2026
RevenueSEK 424.00K
Net income-SEK 6.19M
Free cash flow-SEK 3.97M
Gross margin52.6%

Valuation Snapshot

latest market cap is SEK 148.48M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	SEK 1.62M	-SEK 26.81M	-SEK 16.05M	109.3%	-0.05	SEK 1.47M	SEK 2.56M	-SEK 470.00K

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-03	SEK 148.48M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About Simris Alg AB (publ)

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

Abera Bioscience AB (ABERA.ST) Ascelia Pharma AB (publ) (ACE) AcouSort AB (ACOU) Active Biotech AB (ACTI) AlzeCure Pharma (ALZCUR) Alzinova (ALZ.ST) Annexin Pharmaceuticals (ANNX.ST) Alligator Bioscience AB (ATORX) BioInvent International (BINV.ST) BioArctic AB (publ) (BIOA-B) Biosergen AS (BIOSGN) Biovica International AB (publ) (BIOVIC-B)

Frequently asked questions

What is Simris Alg AB (publ)'s market cap?

Simris Alg AB (publ)'s market capitalization is SEK 148.48M.